Experts
Supporters
About Mirrors of Medicine
Disease Area
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
my dashboard
Join
Login
EN
EN
FR
DE
IT
ES
RU
UK
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
Method
Experts
Supporters
Principles
About Mirrors of Medicine
Contact
Breast cancer
NEW --- Theragnostic testing – choosing the right therapy in mTNBC
Editor in chief
Experts & associates
Background & relevance
Last update: 16-11-2023
View the PinPoint cases (
) and get feedback
gBRCA mutation, PD-L1 negative (1)
gBRCA mutation, PD-L1 negative (2)
gBRCA mutation, PD-L1 positive
No gBRCA mutation, PD-L1 negative
No gBRCA mutation, PD-L1 positive (1)
No gBRCA mutation, PD-L1 positive (2)
No gBRCA mutation, PD-L1 positive (3)
No gBRCA mutation, PD-L1 positive (4)
Progression on first-line treatment
Progression on second-line treatment
De novo mTNBC